Immix Biopharma, Inc. (IMMX) Financials
IMMX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 22.5 million | 2.8 million |
2023-06-30 | 15.6 million | 2.4 million |
2023-03-31 | 13.2 million | 1.5 million |
2022-12-31 | 14.9 million | 1.7 million |
IMMX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.1 million | 737325 |
2023-06-30 | -3.5 million | 447656 |
2023-03-31 | -2.1 million | 329919 |
2022-12-31 | -3.9 million | 230094 |
IMMX Net Income
No data available :(
IMMX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 19.6 million | - | - |
2023-06-30 | 12.7 million | - | - |
2023-03-31 | 11.5 million | - | - |
2022-12-31 | 13.4 million | - | - |
IMMX Shares Outstanding
IMMX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 38912 | 2.1 million | 2.4 million | - |
2023-06-30 | - | 2.2 million | 1.5 million | - |
2023-03-31 | - | 1.3 million | 1.2 million | - |
2022-12-31 | - | 2.3 million | 1.5 million | - |
IMMX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1381 |
2023-06-30 | - | 506 |
2023-03-31 | - | 505 |
2022-12-31 | -89.5 million | 566 |
IMMX
Price: $2.13
52 week price:
Earnings Per Share: -0.89 USD
P/E Ratio: -3.08
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 12035
Market Capitalization: 72.9 million